Coronation 发表于 2025-3-25 05:24:30

Submitted on: 16 March 2013.
Revised on: 11 May 2013.
Accepted on: 09 June 2013.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

ARCH 发表于 2025-3-25 09:15:28

Submitted on: 30 January 2013.
Revised on: 08 March 2013.
Accepted on: 28 April 2013.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Arroyo 发表于 2025-3-25 15:22:41

Submitted on: 05 February 2007.
Revised on: 11 April 2007.
Accepted on: 26 May 2007.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

证实 发表于 2025-3-25 19:54:08

http://reply.papertrans.cn/1/84/8346/8346-24.png

Defense 发表于 2025-3-25 23:54:51

Submitted on: 22 June 2015.
Revised on: 22 July 2015.
Accepted on: 13 August 2015.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Reverie 发表于 2025-3-26 00:43:13

Submitted on: 03 October 2008.
Revised on: 15 December 2008.
Accepted on: 30 December 2008.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

未成熟 发表于 2025-3-26 07:11:36

Submitted on: 16 February 2017.
Revised on: 03 April 2017.
Accepted on: 26 April 2017.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

FLEET 发表于 2025-3-26 10:48:20

Submitted on: 26 February 2023.
Revised on: 11 June 2023.
Accepted on: 15 July 2023.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

PLUMP 发表于 2025-3-26 14:22:32

http://reply.papertrans.cn/1/84/8346/8346-29.png

排斥 发表于 2025-3-26 18:50:52

Submitted on: 05 September 2022.
Revised on: 18 October 2022.
Accepted on: 18 November 2022.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets
页: 1 2 [3] 4
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (ENDOC